Discovery of a brain-permeable bromodomain and extra terminal domain (BET) inhibitor with selectivity for BD1 for the treatment of multiple sclerosis
- Resource Type
- Article
- Source
- In
European Journal of Medicinal Chemistry 5 February 2024 265 - Subject
- Language
- ISSN
- 0223-5234